Opioids, Bulimia, and Alcohol Abuse & Alcoholism

  • Larry D. Reid
Conference proceedings

Table of contents

  1. Front Matter
    Pages i-xi
  2. Background

    1. Front Matter
      Pages 1-1
    2. Kenneth D. Wild, Larry D. Reid
      Pages 3-21
    3. Larry D. Reid, David J. Carpenter
      Pages 23-48
    4. Ellen M. Unterwald, R. Suzanne Zukin
      Pages 49-72
    5. George T. Bain, Conan Kornetsky
      Pages 73-87
  3. Opioids and Ingestion

    1. Front Matter
      Pages 89-89
    2. Steven J. Cooper, Tim C. Kirkham
      Pages 91-110
    3. Larry D. Reid, Kenneth D. Wild, Michael A. Bozarth
      Pages 111-119
  4. Using Opioid-Antagonists in Treating Bulimia

    1. Front Matter
      Pages 121-121
    2. Jeffrey M. Jonas
      Pages 123-130
    3. Sharon A. Alger, Michael J. Schwalberg, Jean M. Bigaouette, Lyn J. Howard, Larry D. Reid
      Pages 131-142
  5. Opioids and AA&A, Preclinical Studies

    1. Front Matter
      Pages 143-143
    2. Christopher L. Hubbell, Larry D. Reid
      Pages 145-174
    3. Sandra H. Marglin, Larry D. Reid
      Pages 175-191
  6. Naltrexone and Alcohol-Dependence

    1. Front Matter
      Pages 193-193
    2. Joseph R. Volpicelli, Charles P. O’Brien, Arthur I. Alterman, Motoi Hayashida
      Pages 195-214
  7. Individual Differences

    1. Front Matter
      Pages 215-215
    2. Janice C. Froehlich, Ting-Kai Li
      Pages 217-228
    3. Christina Gianoulakis, Panagoula Angelogianni, Micheal Meaney, Joseph Thavundayil, Victor Tawar
      Pages 229-246
  8. Prospectives

    1. Front Matter
      Pages 259-259
    2. Larry D. Reid
      Pages 289-304
  9. Back Matter
    Pages 305-393

About these proceedings


This text is the written form of the proceedings of a satellite symposium associated with the 1988-meeting of the Society for Neu­ roscience. The symposium was held 12 November 1988 in the auditor­ ium of the Addictions Research Foundation, Toronto, Canada. The ac­ tual writing took place across the months following the symposium. The symposium was sponsored by the Addictions Research Foundation, Toronto, Canada, the National Institute on Alcohol Abuse and Alcoholism, U. S. A. , and Rensselaer, Troy, NY, U. S. A. Du Pont Pharmaceuticals provided some financial assistance. Contributors also received specific support for their own projects and these are ac­ knowledged at the end of each chapter. The accomplishment of science involves the efforts of many persons and their organizations. That is surely manifest in the work presented here. Modern science is very expensive and, consequently, financial resouces must be developed and distributed wisely. Those who facilitate this basic function have the appreciation of those of us who need the resources to do our work. There are a large number of individuals whose names will not appear in these pages that make sub­ stantial contributions. We are thankful for their daily contributions. The people who provide the money, those who distribute it, and those who help us do our work have the legitimate expectation that the sci­ entists who use the resources will use it prudently. We hope that your expectations are fulfilled, and sincerely appreciate your efforts.


Alkoholismus Anorexia nervosa Bulimie Opiattherapie alcohol alcoholism anorexia bulimia development drugs obesity opioid patients research treatment

Editors and affiliations

  • Larry D. Reid
    • 1
  1. 1.Rensselaer Polytechnic InstituteTroyUSA

Bibliographic information